| Medical and Health Sciences | 2021-2025 | 167 | US 62 | 99.97 |
| Psychiatry and Mental health | Lifetime | 82 | US 48 | 99.76 |
| Medical Physiology | Lifetime | 312 | US 180 | 99.49 |
| Clinical Neurology | Lifetime | 844 | US 386 | 94.84 |
| Complementary and Alternative Medicine | Lifetime | 731 | US 252 | 93.56 |
| Psychiatry and Mental health | 2021-2025 | 12 | US 5 | 99.89 |
| Medical Physiology | 2021-2025 | 25 | US 13 | 99.64 |
| Epidemiology | 2021-2025 | 547 | US 186 | 95.00 |
| Public, Environmental and Occupational Health | 2021-2025 | 565 | US 213 | 94.60 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 270 | US 112 | 94.05 |
| Econometrics and Quantitative Economics | 2021-2025 | 943 | US 273 | 93.73 |
| Clinical Neurology | 2021-2025 | 292 | US 116 | 91.06 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 494 | US 178 | 89.82 |
| Neuroscience of Neurology | 2021-2025 | 249 | US 88 | 85.13 |
| Dementia and Cognitive Impairment Research | Lifetime | 51 | US 24 | 99.80 |
| Alzheimer's disease research and treatments | Lifetime | 99 | US 55 | 99.73 |
| Sphingolipid Metabolism and Signaling | Lifetime | 40 | US 22 | 98.84 |
| Frailty in Older Adults | Lifetime | 292 | US 116 | 97.66 |
| Health, Environment, Cognitive Aging | Lifetime | 158 | US 79 | 97.45 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 794 | US 356 | 97.09 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 799 | US 267 | 94.14 |
| Menopause: Health Impacts and Treatments | Lifetime | 472 | US 275 | 92.72 |
| Cognitive Functions and Memory | Lifetime | 294 | US 128 | 89.68 |
| Cancer-related cognitive impairment studies | Lifetime | 775 | US 396 | 86.67 |
| Sex and Gender in Healthcare | Lifetime | 398 | US 222 | 82.05 |
| Ginkgo biloba and Cashew Applications | Lifetime | 873 | US 201 | 76.57 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 19 | US 12 | 99.84 |
| Alzheimer's disease research and treatments | 2021-2025 | 27 | US 16 | 99.71 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 131 | US 38 | 98.23 |
| Estrogen and related hormone effects | 2021-2025 | 23 | US 13 | 97.16 |
| Advanced Neuroimaging Techniques and Applications | 2021-2025 | 166 | US 57 | 96.40 |
| Menopause: Health Impacts and Treatments | 2021-2025 | 46 | US 18 | 94.10 |
| Health disparities and outcomes | 2021-2025 | 756 | US 262 | 91.49 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 819 | US 253 | 91.87 |
| Frailty in Older Adults | 2021-2025 | 673 | US 136 | 90.45 |
| Health, Environment, Cognitive Aging | 2021-2025 | 402 | US 183 | 87.10 |
| Cancer-related cognitive impairment studies | 2021-2025 | 225 | US 102 | 85.97 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 358 | US 71 | 84.57 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 605 | US 186 | 85.22 |
| Chronic Disease Management Strategies | 2021-2025 | 886 | US 160 | 84.07 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 667 | US 220 | 80.96 |
| Cerebrospinal fluid and hydrocephalus | 2021-2025 | 955 | US 323 | 78.43 |
| Sex and Gender in Healthcare | 2021-2025 | 147 | US 54 | 78.58 |
| Telomeres, Telomerase, and Senescence | 2021-2025 | 432 | US 167 | 74.33 |
| Sphingolipid Metabolism and Signaling | 2021-2025 | 750 | US 198 | 57.70 |
| Cognitive Functions and Memory | 2021-2025 | 418 | US 136 | 52.83 |
